[Ovid] Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Gu谷rinNave Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes |
|
This post will be closed automatically in 2026-10-24 07:30
Best Answer
7 day(s) ago
|
| |
post
reply
points
490
40
Efficacy of a Meta-Analysis每Recommended Immersion Protocol vs. Field-Practical Cold-Water Immersion Protocol for Performance Recovery: A Randomized Crossover Trial
10
Suspected Rosuvastatin-Associated Bullous Pemphigoid: A Diagnostic and Therapeutic Challenge
10
MYCOPHENOLIC ACID INCREASES APOPTOSIS, LYSOSOMES AND LIPID DROPLETS IN HUMAN LYMPHOID AND MONOCYTIC CELL LINES
10
Infusion Therapy Nursing Team: Implementation and Effectiveness of Initial Results
10
Hypodermoclysis for Fluid Administration in Hospitalized Pediatric Patients
